• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲羟戊酸对于猪和人血管平滑肌细胞的体外生长至关重要。

Mevalonate is essential for growth of porcine and human vascular smooth muscle cells in vitro.

作者信息

Rogler G, Lackner K J, Schmitz G

机构信息

Institut für Klinische Chemie und Laboratoriumsmedizin Universität Regensburg, FRG.

出版信息

Basic Res Cardiol. 1995 Nov-Dec;90(6):443-50. doi: 10.1007/BF00788536.

DOI:10.1007/BF00788536
PMID:8773189
Abstract

The effects of mevalonate depletion on growth and cell cycle kinetics of porcine and human vascular smooth muscle cells (SMC) were studied by growth curves and flow cytometric determination of cell cycle distribution. Porcine and human SMC were growth arrested by serum depletion for 48 h. Subsequently, they were stimulated to maximal growth and DNA synthesis by addition of serum. There was a concentration dependent decrease in the proliferation of human and porcine SMC, when cells were incubated in the presence of fluvastatin, a new, fully synthetic HMGCoA-reductase inhibitor. The reduction of cell number was significant with 10(-5) M and 10(-4)M fluvastatin. The highest concentration induced cell loss after prolonged incubation (> 4 days). The G/S-phase transition of human and porcine vascular SMC was reduced to 50% of controls by 10(-4) M fluvastatin as revealed by cell cycle analysis. The effects of fluvastatin on growth kinetics and cell cycle distribution could be completely reversed by the addition of 1 mM mevalonolactone. This indicates that the inhibitory effect of fluvastatin is caused by the inhibition of HMGCoA-reductase and depletion of mevalonate rather than being unspecific. Addition of LDL to supply cholesterol failed to support cell growth and transition of smooth muscle cells from G(zero)/G1-phase to S-phase, even though LDL was taken up by the cells as shown by confocal fluorescence microscopy. Neither did the addition of squalene or cholesterol to the culture medium normalize cell growth. It is concluded that nonsterol products that are synthesized from mevalonate are necessary for growth of smooth muscle cells. HMGCoA-reductase inhibitors like fluvastatin block the synthesis of these nonsterol precursors in human and porcine vascular SMC in vitro and are therefore growth inhibitory.

摘要

通过生长曲线和细胞周期分布的流式细胞术测定,研究了甲羟戊酸耗竭对猪和人血管平滑肌细胞(SMC)生长及细胞周期动力学的影响。猪和人SMC通过血清剥夺生长停滞48小时。随后,通过添加血清刺激它们达到最大生长和DNA合成。当细胞在新型全合成HMGCoA还原酶抑制剂氟伐他汀存在下孵育时,人和猪SMC的增殖呈浓度依赖性降低。10⁻⁵ M和10⁻⁴ M氟伐他汀时细胞数量减少显著。最高浓度在长时间孵育(>4天)后导致细胞丢失。细胞周期分析显示,10⁻⁴ M氟伐他汀使人和猪血管SMC的G/S期转换降至对照的50%。添加1 mM甲羟戊酸内酯可完全逆转氟伐他汀对生长动力学和细胞周期分布的影响。这表明氟伐他汀的抑制作用是由HMGCoA还原酶抑制和甲羟戊酸耗竭引起的,而非非特异性的。添加低密度脂蛋白(LDL)以供应胆固醇未能支持细胞生长和平滑肌细胞从G₀/G₁期向S期的转换,尽管共聚焦荧光显微镜显示细胞摄取了LDL。向培养基中添加角鲨烯或胆固醇也未使细胞生长恢复正常。结论是,由甲羟戊酸合成的非甾醇产物是平滑肌细胞生长所必需的。像氟伐他汀这样的HMGCoA还原酶抑制剂在体外阻断人和猪血管SMC中这些非甾醇前体的合成,因此具有生长抑制作用。

相似文献

1
Mevalonate is essential for growth of porcine and human vascular smooth muscle cells in vitro.甲羟戊酸对于猪和人血管平滑肌细胞的体外生长至关重要。
Basic Res Cardiol. 1995 Nov-Dec;90(6):443-50. doi: 10.1007/BF00788536.
2
Effects of fluvastatin on growth of porcine and human vascular smooth muscle cells in vitro.氟伐他汀对猪和人血管平滑肌细胞体外生长的影响。
Am J Cardiol. 1995 Jul 13;76(2):114A-116A. doi: 10.1016/s0002-9149(05)80031-1.
3
Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase.甲羟戊酸途径与动脉肌细胞增殖之间的关系:使用HMG-CoA还原酶抑制剂的体外研究
Atherosclerosis. 1993 Jun;101(1):117-25. doi: 10.1016/0021-9150(93)90107-6.
4
Requirement for mevalonate in acetylated LDL induction of cholesterol esterification in macrophages.巨噬细胞中乙酰化低密度脂蛋白诱导胆固醇酯化对甲羟戊酸的需求。
Atherosclerosis. 1993 Dec;104(1-2):19-26. doi: 10.1016/0021-9150(93)90172-q.
5
HMG-CoA reductase inhibitors prevent migration of human coronary smooth muscle cells through suppression of increase in oxidative stress.HMG-CoA还原酶抑制剂通过抑制氧化应激增加来阻止人冠状动脉平滑肌细胞迁移。
Arterioscler Thromb Vasc Biol. 2001 Jun;21(6):937-42. doi: 10.1161/01.atv.21.6.937.
6
Pathogenesis of atherosclerosis and the role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.动脉粥样硬化的发病机制及3-羟基-3-甲基戊二酰辅酶A还原酶抑制剂的作用
Am J Cardiol. 1995 Jul 13;76(2):21A-28A. doi: 10.1016/s0002-9149(05)80011-6.
7
Direct effects of statins on the vascular wall.他汀类药物对血管壁的直接作用。
J Cardiovasc Pharmacol. 1998 May;31(5):773-8. doi: 10.1097/00005344-199805000-00017.
8
HMG-CoA reductase inhibitors reduce acetyl LDL endocytosis in mouse peritoneal macrophages.HMG-CoA还原酶抑制剂可减少小鼠腹腔巨噬细胞中乙酰化低密度脂蛋白的内吞作用。
Arterioscler Thromb Vasc Biol. 1995 Sep;15(9):1352-8. doi: 10.1161/01.atv.15.9.1352.
9
HMG-CoA reductase inhibitors reduce interleukin-6 synthesis in human vascular smooth muscle cells.HMG-CoA还原酶抑制剂可降低人血管平滑肌细胞中白细胞介素-6的合成。
Cardiovasc Drugs Ther. 2002 Mar;16(2):121-6. doi: 10.1023/a:1015701415588.
10
Fluvastatin prevents vascular hyperplasia by inhibiting phenotype modulation and proliferation through extracellular signal-regulated kinase 1 and 2 and p38 mitogen-activated protein kinase inactivation in organ-cultured artery.氟伐他汀通过抑制表型调节和增殖,经由细胞外信号调节激酶1和2以及p38丝裂原活化蛋白激酶失活,从而预防器官培养动脉中的血管增生。
Arterioscler Thromb Vasc Biol. 2005 Feb;25(2):327-33. doi: 10.1161/01.ATV.0000152611.50953.e2. Epub 2004 Dec 9.

本文引用的文献

1
Polypeptide growth factors and atherosclerosis.多肽生长因子与动脉粥样硬化。
Trends Cardiovasc Med. 1991 Oct-Nov;1(7):277-82. doi: 10.1016/1050-1738(91)90043-E.
2
The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.人血清中超离心分离的脂蛋白的分布及化学组成
J Clin Invest. 1955 Sep;34(9):1345-53. doi: 10.1172/JCI103182.
3
Isoprenoid regulation of cell growth: identification of mevalonate-labelled compounds inducing DNA synthesis in human breast cancer cells depleted of serum and mevalonate.
类异戊二烯对细胞生长的调节:在血清和甲羟戊酸缺乏的人乳腺癌细胞中鉴定诱导DNA合成的甲羟戊酸标记化合物。
J Cell Physiol. 1993 Jun;155(3):539-48. doi: 10.1002/jcp.1041550312.
4
The pathogenesis of atherosclerosis: a perspective for the 1990s.动脉粥样硬化的发病机制:20世纪90年代的展望
Nature. 1993 Apr 29;362(6423):801-9. doi: 10.1038/362801a0.
5
Importance of mevalonate-derived products in the control of HMG-CoA reductase activity and growth of human lung adenocarcinoma cell line A549.甲羟戊酸衍生产品在控制HMG-CoA还原酶活性及人肺腺癌细胞系A549生长中的重要性。
Int J Cancer. 1993 Oct 21;55(4):640-5. doi: 10.1002/ijc.2910550421.
6
Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase.甲羟戊酸途径与动脉肌细胞增殖之间的关系:使用HMG-CoA还原酶抑制剂的体外研究
Atherosclerosis. 1993 Jun;101(1):117-25. doi: 10.1016/0021-9150(93)90107-6.
7
Mevalonate is essential for growth activation of human fibroblasts: evidence for a critical role of protein glycosylation in the prereplicative period.甲羟戊酸对于人成纤维细胞的生长激活至关重要:蛋白质糖基化在复制前期起关键作用的证据。
Exp Cell Res. 1994 Jun;212(2):359-66. doi: 10.1006/excr.1994.1155.
8
Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.采用系列定量动脉造影术评估HMG-CoA还原酶抑制剂单一疗法对冠状动脉粥样硬化进展的影响。加拿大冠状动脉粥样硬化干预试验。
Circulation. 1994 Mar;89(3):959-68. doi: 10.1161/01.cir.89.3.959.
9
Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS).辛伐他汀对冠状动脉粥样硬化的影响:多中心抗动脉粥样硬化研究(MAAS)。
Lancet. 1994 Sep 3;344(8923):633-8.
10
Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens.培养的主动脉平滑肌对血清促细胞分裂剂的表型依赖性反应。
J Cell Biol. 1981 May;89(2):379-83. doi: 10.1083/jcb.89.2.379.